BroadPharm has filed a new non-provisional US patent for PEGylated cyanines.
BroadPharm, a leading customer-focused biotech company, has filed a new patent which covers functionalized PEGylated cyanine compounds and their applications. The incorporation of PEG into cyanine dyes has greatly improved the dye’s hydrophilicity. The introduction of a variety of functional groups broadens the applications of these cyanine dyes in biolabeling, imaging and other fields.
“The filing of this new patent will further strengthen BroadPharm's leading position in PEGylation and biolabeling field.” said David Zhang, Chief Executive Officer of BroadPharm.
For products, go to http://bit.ly/2q4gX0L.